drugset

drugset / Trial / NCT05045443

Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia

NCT05045443 ↗

Phase 2 Completed 30 enrolled Ain Shams University

RandomizedParallel-groupOpen-labelSupportive care

Summary

Assessment of of the biological effects of curcumin on microbiota in children with acute lymphoblastic leukemia

Timeline

Start: 2021-08-22
Primary completion: 2022-12-31
Completion: 2024-01-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Curcumin	Small molecule	500 mg	Oral

Indications